Quote | Sharps Technology Inc. Warrant (NASDAQ:STSSW)
Last: | $0.073 |
---|---|
Change Percent: | -0.55% |
Open: | $0.073 |
Close: | $0.073 |
High: | $0.073 |
Low: | $0.073 |
Volume: | 2,720 |
Last Trade Date Time: | 06/28/2024 03:00:00 am |
News | Sharps Technology Inc. Warrant (NASDAQ:STSSW)
NEW YORK, June 17, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. , (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, has made the first shipment of its 1mL and 3mL ...
NEW YORK, June 14, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. , (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, is pleased to invite investors to a webinar...
Message Board Posts | Sharps Technology Inc. Warrant (NASDAQ:STSSW)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Sharps Technology Inc. Warrant Company Name:
STSSW Stock Symbol:
NASDAQ Market:
NEW YORK, June 17, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. , (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, has made the first shipment of its 1mL and 3mL ...
NEW YORK, June 14, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. , (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, is pleased to invite investors to a webinar...
Signed PO secures first 12 months of syringe product orders against Sharps and Nephron’s five-year, $200 million Syringe Sales Agreement. Current Asset Purchase Agreement closing timeline is on track for expected prefillable syringe product shipments to begin by Q2 of 2025. ...